CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

Introducing the latest stable-labeled therapeutic drug monitoring (TDM) standard from Cerilliant, Busulfan-D8.

Busulfan-D8, 100 ug/mL, 1mL B-068
100 ug/mL in Methanol

Used in the treatment of cancer, busulfan is an alkylating antineoplastic drug monitored by clinical labs to ensure patients remain within the drug’s therapeutic range. Adverse reactions to busulfan include vomiting, anorexia, anemia, infertility and bone marrow suppression. This stable-labeled internal standard is suitable for quantification of busulfan levels by GC/MS or LC-MS/MS for applications such as therapeutic drug monitoring or clinical and diagnostic testing.

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements

© 2021 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn